Digital repository of Slovenian research organisations

Show document
A+ | A- | Help | SLO | ENG

Title:Urokinase plasminogen activator (uPA) and plasminogen activator inhibitor type-1 (PAI-1) in breast cancer : correlation with traditional prognostic factors
Authors:ID Lampelj, Maja (Author)
ID Arko, Darja (Author)
ID Čas-Sikošek, Nina (Author)
ID Kavalar, Rajko (Author)
ID Ravnik, Maja (Author)
ID Jezeršek Novaković, Barbara (Author)
ID Dobnik, Sarah (Author)
ID Fokter Dovnik, Nina (Author)
ID Takač, Iztok (Author)
Files:URL URL - Source URL, visit http://www.degruyter.com/view/j/raon.ahead-of-print/raon-2014-0049/raon-2014-0049.xml?format=INT
 
.pdf PDF - Presentation file, download (571,67 KB)
MD5: D89A179898763D1F7B9C795AF15503D7
 
Language:English
Typology:1.01 - Original Scientific Article
Organization:Logo OI - Institute of Oncology
Abstract:Background. Urokinase plasminogen activator (uPA) and plasminogen activator inhibitor type-1 (PAI-1) play a key role in tumour invasion and metastasis. High levels of both proteolytic enzymes are associated with poor prognosis in breast cancer patients. The purpose of this study was to evaluate the correlation between traditional prognostic factors and uPA and PAI-1 expression in primary tumour of breast cancer patients. Patients and methods. 606 primary breast cancer patients were enrolled in the prospective study in the Department of gynaecological oncology and breast oncology at the University Medical Centre Maribor between the years 2004 and 2010. We evaluated the traditional prognostic factors (age, menopausal status, tumour size, pathohistological type, histologic grade, lymph node status, lymphovascular invasion and hormone receptor status), together with uPA and PAI-1. We used Spearman%s rank correlation, Mann Whitney U test and X2 test for statistical analysis. Results. Our findings indicate a positive correlation between uPA and tumour size (p < 0.001), grade (p < 0.001), histological type (p < 0.001), lymphovascular invasion (p = 0.01) and a negative correlation between uPA and hormone receptor status (p < 0.001). They also indicate a positive correlation between PAI-1 and tumour size (p = 0.004), grade (p < 0.001), pathohistological type (p < 0.001) and negative correlation between PAI-1 and hormone receptor status (p = 0.002). Conclusions. Our study showed a relationship between uPA and PAI-1 and traditional prognostic factors. Their role as prognostic and predictive factors remains to be further evaluated.
Keywords:urokinase plasminogen activator, plasminogen activator inhibitor, breast cancer
Publication status:Published
Publication version:Version of Record
Publication date:01.12.2015
Publisher:Association of Radiology and Oncology
Year of publishing:2015
Number of pages:str. 357-364, IV
Numbering:Vol. 49, no. 4
Source:Ljubljana
PID:20.500.12556/DiRROS-18728 New window
UDC:618.19-006
ISSN on article:1318-2099
DOI:10.2478/raon-2014-0049 New window
COBISS.SI-ID:1979259 New window
Copyright:by Authors
Publication date in DiRROS:17.04.2024
Views:482
Downloads:276
Metadata:XML DC-XML DC-RDF
:
Copy citation
  
Share:Bookmark and Share


Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Record is a part of a journal

Title:Radiology and oncology
Shortened title:Radiol. oncol.
Publisher:Slovenian Medical Society - Section of Radiology, Croatian Medical Association - Croatian Society of Radiology
ISSN:1318-2099
COBISS.SI-ID:32649472 New window

Secondary language

Language:Slovenian
Keywords:dojke, rak (medicina), urokinaza, aktivator plazminogena, plazminogen


Back